Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2011
12/21/2011EP2397462A2 Compounds, compositions and methods of treatment for heart failure
12/21/2011EP2396307A1 Novel amino azaheterocyclic carboxamides
12/21/2011EP2396300A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
12/21/2011EP2396298A1 Novel substituted indanes, method for the production thereof, and use thereof as drugs
12/21/2011EP2396004A1 Selective kinase inhibitors
12/21/2011EP2395992A2 Chemically programmed vaccination
12/21/2011EP2178859B1 Condensed anthranilamide derivatives as insectisides
12/21/2011EP2167484B1 Condensed anthranilamide insecticides
12/21/2011EP2079732B1 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
12/21/2011EP1966156B1 New compounds iii
12/21/2011EP1880995B1 Method for producing indole derivative having piperidine ring
12/21/2011EP1663971B1 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
12/21/2011CN1968946B 苯并咪唑酮羧酸衍生物 Benzimidazol-carboxylic acid derivatives
12/21/2011CN102292397A 有机黑色颜料及其制备 Organic black pigment and preparation
12/21/2011CN102292322A 用于治疗例如癌症的疾病的取代的嘧啶 Substituted pyrimidines for the treatment of diseases such as cancer
12/21/2011CN102292321A 作为前列环素(pgi2)受体调节剂用于治疗该受体相关病症的吡唑基取代的碳酸衍生物 Carbonic acid derivatives as prostacyclin (pgi2) receptor modulators for the treatment of the receptor-associated disorder substituted pyrazole
12/21/2011CN102292320A 作为glyt-1抑制剂的芳酰基氨基-和杂芳酰基氨基-取代的哌啶类 As glyt-1 inhibitors aroylamino - and heteroaryl acylamino - substituted piperidines
12/21/2011CN102285973A 一种盐酸帕罗西汀化合物及其制法 An paroxetine hydrochloride Jiqizhifa
12/21/2011CN102285972A 一种制备替加氟的方法 A process for the preparation of tegafur
12/21/2011CN102285945A Method for preparing alpha-carbonyl epoxy compound
12/21/2011CN102285906A Process for preparation of ezetimibe and derivatives thereof
12/21/2011CN101684115B 4-(5-((2-(4-吗啉基-6-苯氨基-1,3,5-三嗪-2-基)亚肼基)甲基)呋喃-2-基)苯甲酸、其制备方法及用途 4- (5 - ((2- (4-morpholino-6-phenyl-1,3,5-triazin-2-yl) hydrazono) methyl) furan-2-yl) benzoic acid, their preparation and use
12/21/2011CN101486683B 哒嗪酮和三嗪酮化合物及其作为药物制剂的用途 Pyridazinone and triazinone compounds and their use as pharmaceutical preparations
12/20/2011US8080666 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
12/20/2011US8080565 Substituted 4-amino-benzylpiperidine compounds
12/20/2011US8080551 HIV inhibiting pyrimidines derivatives
12/20/2011CA2602738C Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
12/20/2011CA2563846C 4-amino-5-cyanopyrimidine derivatives
12/20/2011CA2492924C Novel piperazinone derivates for the treatment of 5-ht2a receptor-related disorders
12/20/2011CA2468562C Hydrazonopyrazole derivatives and their use as therapeutics
12/15/2011WO2011156775A2 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
12/15/2011WO2011156728A2 Zinc sensors for cellular imaging
12/15/2011WO2011156626A1 Antimicrobial agents
12/15/2011WO2011156518A2 Estrogen receptor modulators and uses thereof
12/15/2011WO2011153942A1 Cyanoquinoline derivatives
12/15/2011WO2011153588A1 Viral polymerase inhibitors
12/15/2011WO2011082354A3 Thiol detection
12/15/2011US20110306767 N-Substituted-Heterocycloalkyloxybenzamide Compounds and Methods of Use
12/15/2011US20110306639 Hydrocarbylidene nitrohydrozinecarboximidamides and a method for making the same, as well as their uses as an insecticide
12/15/2011US20110306637 Modulators of atp-binding cassette transporters
12/15/2011US20110306602 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
12/15/2011US20110306595 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
12/15/2011US20110306592 Cyclohexyl-azetidinyl antagonists of ccr2
12/15/2011US20110306591 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
12/15/2011US20110306590 Aryl- and heteroaryl- nitrogen-heterocyclic compounds as pde10 inhibitors
12/15/2011US20110306589 Nitrogen containing heteroaryl compounds
12/15/2011US20110306587 Unsaturated nitrogen heterocyclic compounds useful as pde10 inhibitors
12/15/2011US20110305762 Pharmaceutical composition comprising n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furyl]-4- quinazolinamine
12/15/2011CA2810162A1 Antimicrobial agents
12/15/2011CA2802130A1 Cyanoquinoline derivatives
12/15/2011CA2800673A1 Estrogen receptor modulators and uses thereof
12/14/2011EP2395573A1 Organic electroluminescent element, and illumination device and display device each comprising the element
12/14/2011EP2395002A1 Pharmaceutical composition containing a heterocyclic modulator of ATP-binding cassette transporters.
12/14/2011EP2394996A1 Phenylimidazole compounds
12/14/2011EP2394995A1 Ring-fused 2-pyridone derivatives and herbicides
12/14/2011EP2394990A1 Indoline derivatives
12/14/2011EP2393815A2 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
12/14/2011EP2393805A1 Xanthene dyes comprising a sulfonamide group
12/14/2011EP2393802A1 Dihydroquinolinone derivatives
12/14/2011EP2393796A1 Novel herbicides
12/14/2011EP2393795A1 Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes
12/14/2011EP2393794A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
12/14/2011EP2393781A1 Dihydropyridone ureas as p2x7 modulators
12/14/2011EP2393769A1 Novel herbicides
12/14/2011EP2393360A1 Pyridazinone compounds
12/14/2011EP2393359A1 Linked dibenzimidazole derivatives
12/14/2011EP2089367B1 Pyrazoline compounds as mineralocorticoid receptor antagonists
12/14/2011EP2021324B1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/14/2011EP1917262B1 Piperidine and piperazine derivatives as p2x3 antagonists
12/14/2011EP1861399B1 Cgrp receptor antagonists
12/14/2011EP1712547B1 Bicycloester derivative
12/14/2011EP1532122B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/14/2011CN102282216A 黑色颜料分散体 Black pigment dispersion
12/14/2011CN102282215A 滤色器用黑色基体 Color filters, black matrix
12/14/2011CN102277154A 一种苯基哌嗪类α<sub>1</sub>-肾上腺素能受体的小分子荧光探针及其应用 One kind of phenyl piperazine α <sub> 1 </ sub> - adrenergic receptor small molecule fluorescent probe and its application
12/14/2011CN102276593A 杂环烯酮腙化合物和制备方法及抗结核菌的应用 Hydrazone compounds and heterocyclic ketene preparation and application of anti-TB
12/14/2011CN102276590A 一种金线莲提取物自旋标记类似物及制备与用途 Anoectochilus one kind of spin-labeled analogues and extract preparation and use
12/14/2011CN102276589A 染料化合物 Dye compound
12/14/2011CN102276588A 一种制备拉呋替丁的新工艺 A new process for the preparation of furosemide pull Ding
12/14/2011CN102276581A N-取代四氢吡啶连吲哚类化合物及其制备方法及应用 N- substituted tetrahydropyridine even indoles and its preparation method and application
12/14/2011CN102276576A 苯甲酰胺化合物及其制备方法 Benzamide compounds and methods
12/14/2011CN102276542A 三氮唑醇类化合物、其制备方法与应用 Triazole alcohol compounds, their preparation and use
12/14/2011CN101676271B 含有不饱和杂环胺的四环素衍生物 Unsaturated heterocyclic amines containing tetracycline derivatives
12/14/2011CN101429194B 类胰蛋白酶抑制剂的制备方法 Preparation tryptase inhibitor
12/14/2011CN101341129B 作为因子xia抑制剂的芳基丙酰胺,芳基丙烯酰胺,芳基丙炔酰胺,或芳基甲基脲类似物 As inhibitors of factor xia aryl propionamide, aryl acrylamide, propyne aryl amide, or an aryl group methylurea analogues
12/14/2011CN101089010B 2'-氟代核苷 2'-fluoro nucleosides
12/13/2011US8076492 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
12/13/2011US8076488 Antiproliferative agents; angiogenesis inhibitors; anticancer agents
12/13/2011US8076367 Benzimidazolylidene propane-1,3-dione derivative or salt thereof
12/13/2011US8076347 (-)-(2S,4S)-1-(2-hydroxymethyl-1,3-dioxolan-4-yl)cytosine (OddC); "L"-nucleoside that exhibits anti-tumor activity; anticarcinogenic agent for non-small cell lung cancer, colon, breast, prostate, ovarian, CNS, renal, and lymphoma cancer, leukemia, melanoma
12/13/2011CA2634769C Nitrogen-containing bicyclic heteroaryl compounds and methods of use
12/13/2011CA2528642C Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
12/13/2011CA2517572C Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/13/2011CA2502528C 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
12/13/2011CA2476008C Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
12/08/2011WO2011151808A1 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
12/08/2011WO2011151621A1 Compounds for the treatment of clostridium difficile associated disease
12/08/2011WO2011151620A1 Compounds for the treatment of clostridium difficile associated disease
12/08/2011WO2011151251A1 New ccr2 antagonists
12/08/2011WO2011151199A1 Spiroheterocyclic pyrrolidine derivatives based pesticides
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 694